Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp